Hanover Insurance (THG) traded up 0.56 % during a 24 hours period ending at 09:03 PM Central Europe on Tuesday 27th. One Hanover Insurance stock can currently be bought for about USD 235.81 on popular exchanges. Current supply of Hanover Insurance stocks is 34.6 mn. Hanover Insurance has a current market capitalization of USD 8.3 bn and approximately USD 50.4 mn worth of Hanover Insurance was traded on exchanges in the last 24 hours. Since last month end, Hanover Insurance has traded 9.88 % up. Simple moving average of last 200 days is at USD 198.87. The highest price of past 52 weeks was recorded at USD 240.97 on 10/26/2026. 52 weeks low was at USD 166.54 on 01/13/2026.

Summary of the latest news for Hanover Insurance

On Tuesday, the London market closed lower, with HSBC and Reckitt Benckiser experiencing disappointing third‑quarter earnings that dampened investor sentiment. Both companies reported performance that fell short of expectations, prompting analysts to view the results as potential early signals of a broader slowdown in UK corporate growth. The weaker updates contributed to a decline in the FTSE 100, which slipped by around one percent. Amid the market movement, inflation data indicated a rise in shop‑price inflation for October, the highest level in more than two years, driven largely by energy and transport costs. This inflation trend, coupled with weaker corporate earnings, has led to calls for policy measures to curb rising household costs. The day’s developments underscored the sensitivity of the UK market to corporate earnings and inflationary pressures.

Here is how related stocks have performed in the past 24 hours:

  • Repligen (RGEN) traded up 1.83 % and now trades at USD 174.67. Repligen has a market capitalisation of USD 10 bn. Repligen has a current price to earnings ratio of 241.35.

  • Antero Midstream (AM) traded down -0.29 % and now trades at USD 20.92. Antero Midstream has a market capitalisation of USD 9.9 bn. Current price/earnings ratio for Antero Midstream is 24.29.

  • Netskope (NTSK) traded up 3.83 % and now trades at USD 26.13. Netskope has a market capitalisation of USD 9.9 bn.

  • Corcept Therapeutics (CORT) traded up 1.48 % and now trades at USD 87.29. Current market capitalisation for Corcept Therapeutics is USD 9.8 bn. Corcept Therapeutics has a current price to earnings ratio of 186.93. Corcept Therapeutics Inc. reported that its antibody‑drug conjugate sacituzumab‑tirumotecan, studied in a large international phase‑III trial, demonstrated a significant reduction in disease progression and mortality in women with recurrent endometrial cancer who had previously received chemotherapy and immunotherapy. The study, which enrolled patients across more than 200 centres in 29 countries, found that the new therapy lowered the risk of tumour growth and death compared with standard chemotherapy alone, and produced higher rates of tumour shrinkage. Side effects were manageable and included low blood counts and mucosal inflammation. The trial’s results, to be presented at the European Society for Medical Oncology meeting and published in The Lancet, suggest that sacituzumab‑tirumotecan may become a new standard of care for this cancer type and could potentially benefit other Trop‑2‑expressing malignancies.

  • Cullen/frost Bankers (CFR) traded up 0.97 % and now trades at USD 158.6. Current market capitalisation for Cullen/frost Bankers is USD 9.9 bn. Current price/earnings ratio for Cullen/frost Bankers is 14.87. On 26 October 2026, several insiders of CULLEN /FROST BANKERS, INC. filed Form 4 reports with the SEC. Executives and officers—including the chief credit officer, president, chief consumer banking officer, chief financial officer, general‑e‑v‑p, and others—reported changes in their holdings of the company’s common stock. Transactions involved both purchases and dispositions of shares, with several officers acquiring additional shares and some disposing of existing holdings. Restricted stock units were also exercised in a few cases, though no new units were granted during the reporting period. These filings reflect routine adjustments to insiders’ portfolios and do not indicate any immediate material events beyond normal share‑ownership activity.

About Hanover Insurance

The Hanover Insurance Group Inc-The is an American financial institution operating in the insurance sector, offering various property and casualty insurance products and services throughout the United States. The company operates in three segments: commercial lines, personal lines, and other. You can find more information about their offerings and operations on their website, www.hanover.com , and they are listed on the New York Stock Exchange. Their initial public offering took place on October 10, 1995.